comparemela.com
Home
Live Updates
Circio Joins Collaboration to Test the Combination of TG01 Vaccination with Daratumumab and Nivolumab in Immunotherapy-Resistant Patients with Mutant RAS Cancers : comparemela.com
Circio Joins Collaboration to Test the Combination of TG01 Vaccination with Daratumumab and Nivolumab in Immunotherapy-Resistant Patients with Mutant RAS Cancers
Circio Holding ASA announced that it has entered into a collaboration with Georgetown University as part of a collaborative research support agreement with Janssen Scientific Affairs, LLC and a drug...
Related Keywords
,
Bristol Myers Squibb
,
Samir Khleif
,
Circio Holding
,
Georgetown University
,
Janssen Scientific Affairs
,
Markets
,
comparemela.com © 2020. All Rights Reserved.